EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 58 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | -100.0% | 619 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 619 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 619 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 619 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 619 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 619 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 41,909,219 | $42,747,000 | 27.52% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 637,696 | $650,000 | 0.13% |
| Integrated Advisors Network LLC | 478,630 | $488,000 | 0.10% |
| BARD ASSOCIATES INC | 79,400 | $81,000 | 0.06% |
| Kore Private Wealth LLC | 202,366 | $206,000 | 0.05% |
| HighTower Advisors, LLC | 5,284,688 | $5,390,000 | 0.04% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 158,520 | $162,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 509,200 | $519,000 | 0.01% |
| Summit X, LLC | 25,500 | $26,000 | 0.01% |
| American Portfolios Advisors | 111,687 | $113,921 | 0.01% |